EPHB2 and colitis: Additionally, Yu et al. explored the effects of EVs from EphB2-overexpressing bone marrow MSCs (EphB2-EVs) in DSS-induced colitis, revealing that EphB2-EVs reduce intestinal mucosal inflammation and accelerate colon tissue repair.